Novel donor-π-acceptor benzimidazole-based chromophores: synthesis, antitumor assessment, and pharmacokinetics
RSC Advances · 2026 · 16 (15) · 13644-13657
DOI: 10.1039/d6ra00254d ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Salhah D Al-Qahtani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University P.O. Box 84428 Riyadh 11671 Saudi Arabia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Princess Nourah Bint Abdulrahman University.
Abstract (Originalsprache)
Benzimidazole hybrids showed selective cytotoxicity against HepG2, PC3, and MCF-7 cancer cells with low toxicity to WI-38 cells. VEGFR-2 inhibition and docking confirmed strong binding, indicating promising anticancer and anti-angiogenic activity.
Autor:innen und Institutionen
- Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University P.O. Box 84428 Riyadh 11671 Saudi Arabia.
- Unit of Genetic Engineering and Biotechnology, Mansoura University El-Gomhoria St. Mansoura 35516 Egypt khaledelattar2@mans.edu.eg.
ORCID-Profile: Ghadah M Al-Senani, Khaled M Elattar
Förderung
- Princess Nourah Bint Abdulrahman University
Zitieren
APA
Al-Qahtani, S. D., Al-Senani, G. M., & Elattar, K. M. (2026). Novel donor-π-acceptor benzimidazole-based chromophores: synthesis, antitumor assessment, and pharmacokinetics. RSC Advances, 16(15), 13644-13657. https://doi.org/10.1039/d6ra00254d
Vancouver
Al-Qahtani SD, Al-Senani GM, Elattar KM. Novel donor-π-acceptor benzimidazole-based chromophores: synthesis, antitumor assessment, and pharmacokinetics. RSC Advances. 2026;16(15):13644-13657. doi:10.1039/d6ra00254d
BibTeX
@article{AlQahtani2026,
author = {Al-Qahtani, Salhah D and Al-Senani, Ghadah M and Elattar, Khaled M},
title = {Novel donor-π-acceptor benzimidazole-based chromophores: synthesis, antitumor assessment, and pharmacokinetics},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {15},
pages = {13644--13657},
doi = {10.1039/d6ra00254d}
}
EUVIMED